Unnecessary PSA Screenings?
Many Elderly Men Are Undergoing Unnecessary PSA Screenings A new study on the use of prostate-specific antigen (PSA)-based prostate cancer screening in the United States found that many elderly men may be undergoing unnecessary prostate cancer screenings. Using data from surveys conducted in 2000 and 2005, researchers report that nearly half of men... more
First FDA-Approved Prostate Cancer Treatment Vaccine
First FDA-Approved Prostate Cancer Treatment Vaccine Available At Roswell Park The nation’s first FDA-approved cancer treatment vaccine, Provenge (sipuleucel-T), is being offered for the first time in Western New York at Roswell Park Cancer Institute (RPCI). The vaccine is designed for men with advanced prostate cancer who have limited treatment... more
Hard Exercise May Reduce the Risk of Prostate Cancer
Risk Of Death For Men With Prostate Cancer May Be Reduced By Exercise, A new study of men with prostate cancer finds that physical activity is associated with a lower risk of overall mortality and of death due to prostate cancer. The Harvard School of Public Health and University of California, San Francisco researchers also found that men who did more... more
Prostate Cancer Treatment Decisions
In Prostate Cancer Treatment Decisions, Age Plays Too Big A Role Older men with high-risk prostate cancer frequently are offered fewer – and less effective – choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study. The scientists found that men above age 75 with high-risk prostate cancer... more
Accurate Diagnosis Of Prostate Cancer With Ultrasound
Prostate cancer is the most common type of cancer among men, but its diagnosis has up to now been inaccurate and unpleasant. Researchers at Eindhoven University of Technology (TU/e) in the Netherlands, in cooperation with AMC Amsterdam, have developed an imaging technology that can accurately identify tumors. The technology is based on ultrasound, and... more
Cholesterol-Lowering Drug Shrinks Enlarged Prostates In Hamster Model
A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH), report researchers at Children’s Hospital Boston and their colleagues in the October issue of the Journal of Urology. Together, the drugs worked even better. “We don’t know the... more
Urine Test For Prostate Cancer Hopeful
New research led by UK scientists has shown that a protein in urine could be a reliable marker for prostate cancer risk, and although there is still a lot of work to be done to move it from the laboratory to the clinic, the finding is raising hopes that an easy and reliable clinical test for prostate cancer is now much closer. The study, led by scientists... more
Robot To Have First Clinical Trial Test In Prostate Cancer Patients
In the first-of-a-kind clinical trial, a robot will be used to place therapeutic radioactive seeds in prostate cancer patients. The National Cancer Institute-supported study, which will enroll 14 patients, has just opened at Thomas Jefferson University Hospital. The robot has been designed by Thomas Jefferson University scientists to provide the steadiest... more
Benign Prostatic Hyperplasia – Symptoms, Causes and Natural Remedies
The prostate is a male gland that secretes the fluid (a part of the semen) which carries sperm from the testicles during ejaculation. The prostate is located just below the bladder and in front of the rectum. It surrounds the first inch of the urethra (the tube through which urine and sperm exit the body). Usually, the prostate gland starts to enlarge... more
Benign Prostate Hyperplasia (BPH) – What Are The Risks?
As men get older the vast majority of them will experience a disorder of the prostate known as benign prostate hyperplasia. BPH, while distressing, is a non-malignant enlargement of the prostate gland. This gland is very small at birth and doesn\’t really begin to grow until the onset of puberty. It reaches full size at around twenty years of... more
